Literature DB >> 32198283

Improving Clinical Islet Transplantation Outcomes.

Bart O Roep1,2.   

Abstract

Year:  2020        PMID： 32198283     DOI： 10.2337/dci19-0080

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  3 in total

1.  BMSCs overexpressed ISL1 reduces the apoptosis of islet cells through ANLN carrying exosome, INHBA, and caffeine.

Authors:  Ying Wang; Jiang-Wei Zhang; Jing-Wen Wang; Jia-Le Wang; Shu-Cong Zhang; Rui-Yang Ma; Jing Zhang; Yang Li; Pei-Jun Liu; Wu-Jun Xue; Jin Zheng; Xiao-Ming Ding
Journal:  Cell Mol Life Sci       Date:  2022-10-03       Impact factor: 9.207

Review 2.  Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.

Authors:  Magdalena M Samojlik; Cherie L Stabler
Journal:  Acta Biomater       Date:  2021-06-05       Impact factor: 10.633

3.  Islet transplantation ameliorates diabetes-induced testicular interstitial fibrosis and is associated with inhibition of TGF-β1/Smad2 pathway in a rat model of type 1 diabetes.

Authors:  Yuan-Cai Zheng; Yi-Ling Feng; Yi-Hong Wang; Li-Jun Kong; Ming-Shi Zhou; Min-Min Wu; Cheng-Yang Liu; Hua-Chun Weng; Hong-Wei Wang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.